News from emd serono, inc A wide array of domestic and global news stories; news topics include politics / government, business, technology, religion, sports/entertainment, science/nature, and health/lifestyle. Articles that appear in this section may be written in English or other languages, as well.

Jun 17, 2015, 08:00 ET

EMD Serono Announces EUR 1.2 million Grant for Fertility Innovation (GFI) for 2015 / 16

 EMD Serono, the U.S. biopharmaceutical business of Merck KGaA, Darmstadt, Germany, today announced its strong support of the Grant...

Jun 08, 2015, 08:06 ET

Merck KGaA, Darmstadt, Germany, Illumina and Genea Form the Global Fertility Alliance for Excellence in Assisted Reproductive Treatment

 Merck KGaA, Darmstadt, Germany, a leading company for innovative and top-quality high-tech products in healthcare, life science and...

May 28, 2015, 11:46 ET

Merck KGaA, Darmstadt, Germany, as Pioneer in Assisted Reproductive Treatments, Takes Leading Role in Fertility Technologies, Announces a Global Collaboration Agreement with Genea Biomedx

 Merck KGaA, Darmstadt, Germany, a leading company for innovative and top-quality high-tech products in healthcare, life science and...

May 28, 2015, 08:12 ET
David Trexler, Senior Vice President of Oncology Commercial

EMD Serono Continues its Entry into Oncology with the Key Appointments of David Trexler to Senior Vice President of Oncology Commercial and Zhen Su, MD, MBA to Vice President of Medical Oncology

EMD Serono, the U.S. biopharmaceutical business of Merck KGaA, Darmstadt, Germany, today announced two critical management appointments to lead its...

May 21, 2015, 09:00 ET
EMD Serono.

Rebif® (interferon beta-1a) Data at CMSC Annual Meeting Highlights Clinical and MRI Predictors for Long Term Outcomes

 EMD Serono, Inc., the U.S. biopharmaceuticals business of Merck KGaA, Darmstadt, Germany, announced today that data about...

May 15, 2015, 03:25 ET

Merck KGaA, Darmstadt, Germany to Present Data at ASCO That Illustrate How the Company is Tackling Difficult-to-Treat Cancers

ASCO Abstract # Avelumab*: 3023, 3044, 3055, TPS9386, TPS3101, 4042, 4047, 5509, 8034; evofosfamide: TPS9089, 8579; tepotinib: 2591;...

May 12, 2015, 06:25 ET

Merck KGaA, Darmstadt, Germany, Receives FDA Fast Track Designation for Evofosfamide for the Treatment of Patients Living With Advanced Pancreatic Cancer

- Evofosfamide is an investigational compound currently in Phase III trials  - Advanced pancreatic cancer is second indication to...

May 06, 2015, 08:00 ET

EMD Serono Initiates Co-Promotion of XALKORI® (crizotinib) with Pfizer in the United States

 EMD Serono, the U.S. biopharmaceutical business of Merck KGaA, Darmstadt, Germany, today announced it has begun co-promoting Pfizer's...

Apr 16, 2015, 09:26 ET
EMD Serono.

EMD Serono Highlights Scientific Commitment to MS with Data Presented at the AAN Annual Meeting

 EMD Serono, the U.S. biopharmaceuticals business of Merck KGaA, Darmstadt, Germany, announced today that data about Rebif® (interferon...

Apr 16, 2015, 08:00 ET
Alise Reicin

Alise Reicin Joins the Biopharmaceutical Business of Merck KGaA, Darmstadt, Germany as Head of Global Clinical Development

 EMD Serono today announced the US biopharmaceutical business of Merck KGaA, Darmstadt, Germany, appointed Alise Reicin, MD, as...

Apr 06, 2015, 10:42 ET

EMD Serono Launches 11th Edition of The EMD Serono Specialty Digest™ at Annual Meeting of The Academy of Managed Care Pharmacy

EMD Serono, the U.S. biopharmaceuticals subsidiary of Merck KGaA, Darmstadt, Germany, today announced the launch of the 11th edition of the EMD...

Apr 01, 2015, 09:30 ET

EMD Serono Appoints Frederick E. Munschauer M.D., FAAN to Vice President of Medical Affairs, Neurology and Immunology

 EMD Serono, the U.S. biopharmaceuticals subsidiary of Merck KGaA, Darmstadt, Germany, announced today the appointment of Frederick...

Mar 10, 2015, 10:00 ET

EMD Serono Announces Strategic Collaboration with Illumina for Diagnostics in Oncology

 EMD Serono today announced that the biopharmaceutical business of Merck KGaA, Darmstadt, Germany has entered into a collaboration with...

Mar 09, 2015, 07:30 ET
141783

EMD Serono and Opexa Amend Agreement to Support Ongoing Development of Tcelna (imilecleucel-T) for Multiple Sclerosis

 EMD Serono, the biopharmaceutical division of Merck KGaA, Darmstadt, Germany, announced today the execution of an amendment to its agreement...

Dec 10, 2014, 08:00 ET
EMD Serono logo.

EMD Serono Continues Leadership Role in Product Integrity by Launching Product Tracking Program and Check My Meds™ Smartphone App

EMD Serono, the biopharmaceutical division of Merck KGaA, Darmstadt, Germany, announced that it has serialized all of its major brands in the U.S.,...

Dec 04, 2014, 02:30 ET

EMD Serono Awards Grant for Growth - Countdown for Accepting Applications

  - EMD Serono's Grant for Growth Innovations (GGI) supports innovative projects to advance understanding in the field of...

Sep 27, 2014, 08:00 ET

EMD Serono Announces Award of $1.3 Million to the Winners of the first Grant for Oncology Innovation

 EMD Serono, the biopharmaceutical division of Merck KGaA, Darmstadt, Germany, today announced the winners of the first Grant for...

Sep 19, 2014, 03:39 ET

EMD Serono Awards Grant for Growth Innovation (GGI) for the First Time

- The first grants awarded to coincide with the 53rd European Society for Paediatric Endocrinology (ESPE) Meeting  - Investment...

Sep 12, 2014, 08:00 ET
EMD Serono. (PRNewsFoto/EMD Serono)

EMD Serono Honors Recipients of the Second Annual EUR 1 Million Grant for Multiple Sclerosis Innovation

 EMD Serono Inc., a subsidiary of Merck KGaA, Darmstadt, Germany, today announced the recipients of the second annual Grant for...

Sep 10, 2014, 09:00 ET
EMD Serono. (PRNewsFoto/EMD Serono)

EMD Serono and Accelerated Cure Project Launch Collaborative Research Program to Optimize Treatment and Understand Progression of Multiple Sclerosis

 EMD Serono, Inc., a subsidiary of Merck KGaA, Darmstadt, Germany and the Accelerated Cure Project for Multiple Sclerosis today...